【摘要】：【目的】探討長鏈非編碼RNA GAS5在卵巢癌中的表達水平及其臨床意義。【方法】收集卵巢癌患者的瘤體組織標本,通過實時熒光定量PCR檢測GAS5在卵巢癌組織中的表達水平。采用相關(guān)性分析,分析其表達水平與臨床病理特征之間的關(guān)系、及其與疾病預后之間的關(guān)系。【結(jié)果】在卵巢癌瘤體組織中GAS5表達顯著下降(P=0.0004);GAS5的表達與瘤體體積呈負相關(guān)(d5 cm vs.d5 cm,P0.000 1);GAS5的表達與腫瘤期別呈負相關(guān)(Ⅰ~Ⅱgrades vs.Ⅲ~Ⅳgrades,P=0.0086)。采用Kaplan-Meier分析表明,GAS5表達水平越低患者預后和生存越差�！窘Y(jié)論】GAS5在卵巢癌中的表達情況與臨床病理特征以及預后相關(guān),可作為潛在的卵巢癌檢測標記物。
[Abstract]:[objective] to investigate the expression of long chain noncoding RNA GAS5 in ovarian cancer and its clinical significance. [methods] the expression of GAS5 in ovarian cancer was detected by real-time fluorescence quantitative PCR. Correlation analysis was used to analyze the relationship between the expression level and clinicopathological features and the prognosis of ovarian cancer. [results] the expression of GAS5 was significantly decreased in ovarian cancer (P0. 0004). The expression of GAS5 was negatively correlated with tumor volume (d5 cm vs.d5 cm,P0.000 1) and GAS5 was negatively correlated with tumor stage (鈪，

本文編號：2315924